483
DermAvance Pharmaceuticals, Inc.FDA 483 - DermAvance Pharmaceuticals, Inc. - July 17, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
DermAvance Pharmaceuticals, Inc., a Commercial Sponsor-Monitor, was cited for a compliance issue during an FDA inspection. The firm failed to submit required annual progress reports for a significant risk device study. Specifically, the annual progress report for 2017 was not submitted to the FDA.
- Person
Open in Dashboard
ID · 4e0a3e44-fbff-411b-be4b-6fb93cbefc61